Cargando…
Prediction of synergistic drug combinations using PCA-initialized deep learning
BACKGROUND: Cancer is one of the main causes of death worldwide. Combination drug therapy has been a mainstay of cancer treatment for decades and has been shown to reduce host toxicity and prevent the development of acquired drug resistance. However, the immense number of possible drug combinations...
Autores principales: | Ma, Jun, Motsinger-Reif, Alison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527604/ https://www.ncbi.nlm.nih.gov/pubmed/34670583 http://dx.doi.org/10.1186/s13040-021-00278-3 |
Ejemplares similares
-
Synergistic Chemotherapy Drug Response Is a Genetic Trait in Lymphoblastoid Cell Lines
por: Roell, Kyle R., et al.
Publicado: (2019) -
Nonlinear Dose–Response Modeling of High-Throughput Screening Data
Using an Evolutionary Algorithm
por: Ma, Jun, et al.
Publicado: (2020) -
Deep learning identifies synergistic drug combinations for treating COVID-19
por: Jin, Wengong, et al.
Publicado: (2021) -
PCA and deep learning based myoelectric grasping control of a prosthetic hand
por: Li, Chuanjiang, et al.
Publicado: (2018) -
Predicting anticancer synergistic drug combinations based on multi-task learning
por: Chen, Danyi, et al.
Publicado: (2023)